Gleason Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.1K Buy
1,005
+6
+0.6% +$525 0.01% 106
2026
Q1
$85.1K Sell
999
-1,642
-62% -$146K 0.01% 101
2025
Q4
$209K Buy
2,641
+18
+0.7% +$1.41K 0.02% 68
2025
Q3
$210K Buy
2,623
+15
+0.6% +$1.28K 0.02% 67
2025
Q2
$237K Buy
2,608
+16
+0.6% +$1.46K 0.03% 63
2025
Q1
$243K Sell
2,592
-1,597
-38% -$143K 0.04% 59
2024
Q4
$381K Buy
4,189
+23
+0.6% +$2.19K 0.07% 51
2024
Q3
$433K Buy
4,166
+20
+0.5% +$2.04K 0.08% 51
2024
Q2
$402K Buy
4,146
+22
+0.5% +$2.03K 0.08% 55
2024
Q1
$371K Buy
4,124
+23
+0.6% +$1.95K 0.08% 56
2023
Q4
$327K Buy
4,101
+26
+0.6% +$1.96K 0.08% 56
2023
Q3
$290K Buy
4,075
+26
+0.6% +$1.94K 0.08% 61
2023
Q2
$312K Buy
4,049
+23
+0.6% +$1.78K 0.08% 62
2023
Q1
$303K Buy
4,026
+26
+0.7% +$1.93K 0.09% 61
2022
Q4
$315K Buy
+4,000
New +$300K 0.1% 59

Other funds holding CL

Gleason Group's CL Position: Q2 2026 in Review

Gleason Group increased its Colgate-Palmolive (CL) stake by 0.6% in Q2 2026, buying an estimated $525 and bringing the position to 1,005 shares worth $92.1K. The position accounts for 0.01% of the portfolio, ranked #106.

Gleason Group first reported a position in CL in Q4 2022 and has held it in 15 quarters since. The position peaked at $433K in Q3 2024. 668 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Gleason Group held 1,005 shares of Colgate-Palmolive worth $92.1K as of Q2 2026.
  • Gleason Group bought 6 Colgate-Palmolive shares in Q2 2026, an estimated $525.
  • Colgate-Palmolive made up 0.01% of Gleason Group's portfolio in Q2 2026, its #106 holding.
  • Gleason Group first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 15 quarters since.
  • Gleason Group's Colgate-Palmolive position peaked at $433K in Q3 2024.
  • 668 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Gleason Group's 13F filing for Q2 2026, filed 13 Jul 2026.